Followers | 7 |
Posts | 5499 |
Boards Moderated | 0 |
Alias Born | 09/11/2013 |
Tuesday, October 23, 2018 10:15:58 AM
Proxy voting for NNVC
EUGENE SEYMOUR
<drgeno@seymour.com>
Oct 22, 2018, 10:55 PM (10 hours ago)
to Eugene
Dear fellow investors:
You can vote your proxy over the internet. Go to www.proxyvote.com and enter your control number. This will be the number found on the proxy postcard that you will receive by mail. Feel free to contact me after October 29th if you have any questions
Here are the issues on the table:
At this year’s annual meeting you will be asked to: (i) elect two directors and re-elect another director who will each serve for a two year term; (ii) approve our Executive Equity Incentive Plan; (iii) approve the award of warrants to purchase 250,000 shares of common stock in connection with the separation agreement of our former Chief Executive Officer; (iv) approve the award of 525,000 shares of Series A Convertible Preferred Stock to our President in connection with his employment agreement; (v) ratify the selection of our independent registered public accountants; and (vi) transact such other business as may properly come before the annual meeting. The accompanying Notice of Meeting and Proxy Statement describe these matters. We urge you to read this information carefully.
(i) OK for the two new directors but NO to the re-election of Stanley Glick
(ii) This gives too much leeway to the Board to grant these awards. I’m concerned that they will be awarded without appropriate oversight: NO
(iii) This enables me to buy shares at $2/share in three equal tranches starting next January 27th and then again in 2020 and 2021. Obviously I have no comment on this
(iv) Should we award Dr. Diwan for not starting toxicology studies, for not selecting a final drug candidate, for not consummating a shingles license agreement and for not scheduling a pre-IND meeting with the FDA. Also, for being the CEO when the stock decreased in value by 70% because none of these promised milestones have been met during this calendar year. NO!
(v) and (vi) are OK
Eugene Seymour MD MPH
310-486-5677
Will the real Ubernano please stand up?
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM